R-Pharm

R-Pharm, founded in 2004, started by supplying pharmaceutical products to hospitals. In 2011, the company acquired Novosibirsk Pharmaceutical Plant and Ordapharm, and established a finished drug manufacturing plant in Yaroslavl. In 2017, Japan’s Mitsui & Co., Ltd. acquired a 10% stake in R-Pharm to help expand its production capacity. To secure Mitsui's sales share in Russia, R-Pharm signed a CT equipment supply contract worth 2.897 billion rubles with the Moscow Department of Health in early 2020. The company's vision is to make modern and effective treatments as accessible to patients as possible. To achieve this goal, we have significantly expanded our portfolio of various drugs, including oncology, antibacterial, antiviral medications, as well as drugs for the treatment of HIV infection.